– Digital health and InsureTech chatbot platform Sensely announced it has raised $15M in funding led by Aflac Corporate Ventures, the venture arm of Aflac Inc.
– The funding brings expanded commercial pathways to Sensely, with markets serving over 60 million members and representing over $200MM in annual recurring revenue opportunities.
Today, at HLTH 2019, Sensely, a San Francisco, CA-based digital health and InsureTech platform that modernizes member experience while lowering costs, announced that it has raised $15M in funding led by Aflac Corporate Ventures, the venture arm of Aflac Inc., the largest supplemental insurance provider in the United States. The funding includes participation from strategic investors that represent the range of current Sensely target markets in insurance, hospital systems, and pharmaceuticals.
Engage Your Members. Reduce Your Costs
Founded in 2013, Sensely’s avatar and chatbot-based platforms assist insurance plan members and patients with the insurance services and healthcare resources they need, when they need it. By utilizing Sensely’s scalable platform technology architecture, enterprises can converse with their members in an entirely new way, combining the empathy of human conversation with the efficiency and scalability of the technology. With offices in London and San Francisco, Sensely’s global teams provide virtual assistant solutions to insurance companies, pharmaceutical clients, and hospital systems worldwide.
Recent Traction
The capital injection comes at a time when Sensely is seeing increasing demand for its multi-lingual AI platform, which uses a voice-enabled character interface, and incorporates into existing enterprise technology infrastructure. Sensely is currently deployed with enterprise customers in the United States, United Kingdom, United Arab Emirates, Netherlands, China, Hong Kong, Japan, Switzerland, and Australia. Customers are using the platform for a diversified set of high-value use cases, including symptom checking, insurance underwriting, claims management, medication management, and remote patient monitoring.
Expanding Commercialization Efforts
Sensely plans to use the latest round of funding to expand its burgeoning commercialization efforts and extend its platform leadership. With the large contingent of strategic investors, the financing also brings expanded commercial pathways to Sensely, with markets serving over 60 million members and representing over $200MM in annual recurring revenue opportunities.
“We’re delighted by the opportunity to work with our new investment partners,” said Adam Odessky, CEO and Co-founder of Sensely. “While we are pleased with our progress over the past year, especially the rollout of our software development kit, we have many important challenges ahead. This funding will ensure that we can strike a balanced approach, continuing to serve our existing partners, while also evolving the platform for the next wave of requested capabilities.”
